And try doing the numbers on 12.5%. Royalty on a market worth $4.5 Billion and likely to grow strongly with the introduction of POH TPM Patches.....
If Pfizer pick up the deal, with their marketing clout, it wont take lomg to build sales...
With a 20 X P.E.. POH will be in the BIOTECH HALL of FAME. With RMD. CSL. COH. SRX....
Once the good analysts realise this there will be more BUYS RATINGS.
Currently Maquarie, Bells and Nomura.
oxymorphone trials begin, page-25
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $11.50K | 4.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 101422109 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 20872825 | 7 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |